Log in to save to my catalogue

The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental ki...

The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental ki...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2653253587

The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation

About this item

Full title

The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation

Publisher

United States: Public Library of Science

Journal title

PloS one, 2022-04, Vol.17 (4), p.e0266319-e0266319

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Interstitial fibrosis and tubular atrophy, a major cause of kidney allograft dysfunction, has been linked to premature cellular senescence. The mTOR inhibitor Rapamycin protects from senescence in experimental models, but its antiproliferative properties have raised concern early after transplantation particularly at higher doses. Its effect on sen...

Alternative Titles

Full title

The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2653253587

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2653253587

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0266319

How to access this item